Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc. (TNYA) Q4 2024 Annual Earnings

TNYA·Reported March 10, 2025·Before market open

Diluted EPS came in at $-0.28, beat the $-0.31 consensus by $0.03.

Diluted EPS
$-0.28beat by $0.03
Consensus: $-0.31
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q4 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Tenaya Therapeutics, Inc.'s Q4 2024 earnings report.

Tenaya Therapeutics, Inc. (TNYA) reported Q4 2024 earnings on March 10, 2025 before market open.

Tenaya Therapeutics, Inc. reported diluted EPS of $-0.28 for Q4 2024.

EPS beat the consensus estimate of $-0.31 by $0.03.

You can read the 10-K periodic report (0000950170-25-036329) directly on SEC EDGAR. The filing index links above go to sec.gov.